[Glucose-6-phosphatase from nuclear envelope in rat liver].
Nuclear envelope (NE) and microsomal glucosa-6-phosphatase (G-6-Pase) activities were compared. Intact microsomes were unable to hydrolyze mannose-6-phosphate (M-6-P), on the other hand, intact NE hydrolyzes this substrate. Galactose-6-phosphate showed to be a good substrate for both NE and microsomal enzymes, with similar latency to that obtained with M-6-P using microsomes. In consequence, this substrate was used to measure the NE integrity. The kinetic parameters (Kii and Kis) of the intact NE G-6-Pase for the phlorizin inhibition using glucose-6-phosphate (G-6-P) and M-6-P as substrates, were very similar. The NE T1 transporter was more sensitive to amiloride than the microsomal T1. The microsomal system was more sensitive to N-ethylmalemide (NEM) than the NE and the latter was insensitive to anion transport inhibitors DIDS and SITS, which strongly affect the microsomal enzyme. The above results allowed to postulate the presence of a hexose-6-phosphate transporter in the NE which is able to carry G-6-P and M-6-P, and perhaps other hexose-6-phosphate which could be different from that present in microsomes or, if it is the same, its activity could by modified by the membrane system where it is included. The higher PPi hydrolysis activity of the intact NE G-6-Pase in comparison to the intact microsomal, suggests differences between the Pi/PPi transport (T2) of both systems. The lower sensitivity of the NE G-6-Pase to NEM suggests that the catalytic subunit of this system has some differences with the microsomal isoform.
González-Mujica
Freddy
F
Sección de Bioquímica Médica, Instituto de Medicina Experimental, Facultad de Medicina, Universidad Central de Venezuela, Sabana Grande, Caracas, Venezuela. gonzalef@cantv.net
D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / Q000494:pharmacology; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid / Q000494:pharmacology; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D017920:Antiporters / Q000378:metabolism; D011756:Diphosphates / Q000378:metabolism; D005033:Ethylmaleimide / Q000494:pharmacology; D005695:Galactosephosphates / Q000378:metabolism; D005952:Glucose-6-Phosphatase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D019298:Glucose-6-Phosphate / Q000378:metabolism; D006868:Hydrolysis; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000378:metabolism; D008099:Liver / Q000201:enzymology*; D008297:Male; D008360:Mannosephosphates / Q000378:metabolism; D008862:Microsomes, Liver / Q000201:enzymology; D009004:Monosaccharide Transport Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D009685:Nuclear Envelope / Q000201:enzymology*; D010695:Phlorhizin / Q000494:pharmacology; D010710:Phosphates / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013379:Substrate Specificity
D017920:Antiporters; D011756:Diphosphates; D005695:Galactosephosphates; D007527:Isoenzymes; D008360:Mannosephosphates; D009004:Monosaccharide Transport Proteins; D010710:Phosphates; C503533:Slc37a4 protein, rat; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; C027693:mannose-6-phosphate; D019298:Glucose-6-Phosphate; C038269:galactose-6-phosphate; D000584:Amiloride; D010695:Phlorhizin; D005952:Glucose-6-Phosphatase; D005033:Ethylmaleimide; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid